SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-003727
Filing Date
2024-01-16
Accepted
2024-01-16 15:57:36
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_bespokeextracts.htm   iXBRL 10-Q 540815
2 CERTIFICATION f10q0923ex31-1_bespoke.htm EX-31.1 10598
3 CERTIFICATION f10q0923ex32-1_bespoke.htm EX-32.1 4113
  Complete submission text file 0001213900-24-003727.txt   4077155

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20230930.xsd EX-101.SCH 52048
5 XBRL CALCULATION FILE bspk-20230930_cal.xml EX-101.CAL 30613
6 XBRL DEFINITION FILE bspk-20230930_def.xml EX-101.DEF 245793
7 XBRL LABEL FILE bspk-20230930_lab.xml EX-101.LAB 482361
8 XBRL PRESENTATION FILE bspk-20230930_pre.xml EX-101.PRE 257472
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_bespokeextracts_htm.xml XML 310063
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 24535093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)